Literature DB >> 9972970

Giant cell arteritis, polymyalgia rheumatica, and viral hypotheses: a multicenter, prospective case-control study. Groupe de Recherche sur l'Artérite à Cellules Géantes.

P Duhaut1, S Bosshard, A Calvet, L Pinede, S Demolombe-Rague, C Dumontet, R Loire, D Seydoux, J Ninet, J Pasquier, M Aymard.   

Abstract

OBJECTIVE: Although suspected, a viral etiology has never been proven in giant cell arteritis (GCA). We tested for viruses known to induce multinucleated giant cells in human pathology, which include the parainfluenza viruses (HPIV), respiratory syncytial virus, measles virus, herpesviruses type 1 and 2, and the Epstein-Barr virus.
METHODS: A multicenter case-control study on incident cases of temporal arteritis (TA) and polymyalgia rheumatica (PMR). Population based age and sex matched controls were randomly selected. Serological tests for IgG and IgM directed against the viruses listed above were performed, on blood samples taken at the time of clinical diagnosis.
RESULTS: Three hundred five new patients were included over a 5 year period, of whom 159 presented with positive biopsy TA, 70 with negative biopsy TA, and 76 with negative biopsy PMR. Thirty-eight percent of cases versus 20.9% of controls were positive for IgM directed against HPIV (p = 0.00005). The association was stronger in the positive TA subgroup [positivity rate 43.31%; odds ratio with controls 2.89 (95% CI 1.82-4.60, p = 0.000006)] than in the PMR or negative biopsy TA subgroups. Only HPIV type 1 was associated with the disease, regardless of the season or the geographical origin of the cases. Positivity rates for HPIV types 2 and 3 and for the other viruses tested were similar in cases and controls.
CONCLUSION: Our findings suggest that reinfection with HPIV type 1 is associated with the onset of GCA in a subset of patients, particularly in cases with positive TA biopsy.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9972970

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  17 in total

1.  Systemic vasculitis: epidemiology, classification and environmental factors.

Authors:  D G Scott; R A Watts
Journal:  Ann Rheum Dis       Date:  2000-03       Impact factor: 19.103

Review 2.  Polymyalgia rheumatica/temporal arteritis: recent advances.

Authors:  Maria-Louise Barilla-LaBarca; Deborah J Lenschow; Richard D Brasington
Journal:  Curr Rheumatol Rep       Date:  2002-02       Impact factor: 4.592

Review 3.  Giant cell arteritis.

Authors:  J M Calvo-Romero
Journal:  Postgrad Med J       Date:  2003-09       Impact factor: 2.401

Review 4.  Giant cell arteritis and polymyalgia rheumatica: pathophysiology and management.

Authors:  Miguel A Gonzalez-Gay; Carlos Garcia-Porrua; Jose A Miranda-Filloy; Javier Martin
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

Review 5.  Diagnosis and treatment of giant cell arteritis.

Authors:  Fabrizio Cantini; Laura Niccoli; Carlotta Nannini; Michele Bertoni; Carlo Salvarani
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

Review 6.  Spectrum of giant cell vasculitis.

Authors:  N Mohan; G Kerr
Journal:  Curr Rheumatol Rep       Date:  2000-10       Impact factor: 4.592

7.  14-3-3 in Thoracic Aortic Aneurysms: Identification of a Novel Autoantigen in Large Vessel Vasculitis.

Authors:  Ritu Chakravarti; Karishma Gupta; Mamuni Swain; Belinda Willard; Jaclyn Scholtz; Lars G Svensson; Eric E Roselli; Gosta Pettersson; Douglas R Johnston; Edward G Soltesz; Michifumi Yamashita; Dennis Stuehr; Thomas M Daly; Gary S Hoffman
Journal:  Arthritis Rheumatol       Date:  2015-07       Impact factor: 10.995

8.  Selective T cell receptor decrease in peripheral blood T lymphocytes of patients with polymyalgia rheumatica and giant cell arteritis.

Authors:  M Lopez-Hoyos; M J Bartolome-Pacheco; R Blanco; V Rodriguez-Valverde; V M Martinez-Taboada
Journal:  Ann Rheum Dis       Date:  2004-01       Impact factor: 19.103

Review 9.  [Giant cell arteritis (temporal arteritis). Pathophysiology, immunology].

Authors:  A D Wagner
Journal:  Ophthalmologe       Date:  2006-04       Impact factor: 1.059

Review 10.  Pathogenesis, Diagnosis and Management of Polymyalgia Rheumatica.

Authors:  Dario Camellino; Andrea Giusti; Giuseppe Girasole; Gerolamo Bianchi; Christian Dejaco
Journal:  Drugs Aging       Date:  2019-11       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.